We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > oncomed

News List

After delayed IPO, Mereo gets US listing via OncoMed merger pharmaphorum
December 10, 2018
UK biotech Mereo BioPharma is merging with Californian biotech OncoMed in an all-stock deal that swells its pipeline and gives it a potential licensing deal with Celgene......
Mereo BioPharma and OncoMed propose merger pharmatimes
December 10, 2018
The transaction will create a combined business with a diversified combined portfolio of seven assets, which will result in an increased number of potential near-term catalysts with a core focus remaining
Celgene walks away from Oncomed’s navicixizumab pharmatimes
September 27, 2018
Celgene has decided not to exercise its option to license OncoMed's bispecific antibody navicixizumab.
OncoMed Cuts Workforce in Half contractpharma
April 26, 2017
Will focus on advancing three clinical-stage programs to milestones